This Week in Healthcare — Brussels (#29, 2026)
Commission marks World Mental Health Day; New biocidal product authorisations and cancellations; EU-Morocco research agreement concluded; Council prepares health policy actions.
October 05, 2026 to October 11, 2026
Commission marks World Mental Health Day; New biocidal product authorisations and cancellations; EU-Morocco research agreement concluded; Council prepares health policy actions.
📋 In This Week's Newsletter
• 📅 This Week's Calendar in Brussels
• 🇪🇺 European Commission
• ⚖️ EU Legislation
• 🤝 EU Council
This Week's Calendar in Brussels
- Environment Council: On October 12, the EU Council's Environment Council configuration is scheduled to hold an ministerial meeting in Brussels.
- Committee on Employment and Social Affairs (EMPL): On October 12, the European Parliament's Committee on Employment and Social Affairs (EMPL) is scheduled to meet. Agenda includes: * * *; Chair’s announcements; Date of next meetings.
- Committee on the Environment, Climate and Food Safety (ENVI): On October 12, the European Parliament's Committee on the Environment, Climate and Food Safety (ENVI) is scheduled to meet. Agenda includes: Chair’s announcements; Date of next meetings; Joint ENVI - ENVE meeting on "Building a sustainable future: funding environmental and climate policies in the Next Multiannual Financial Framework".
- Committee on Public Health (SANT): On October 15, the European Parliament's Committee on Public Health (SANT) is scheduled to meet. Agenda includes: Chair’s announcements; Date of next meetings; *** End of electronic vote ***.
European Commission
Commissioner Várhelyi addresses EU mental health priorities on World Mental Health Day
Ahead of World Mental Health Day, Commissioner Olivér Várhelyi issued a statement referencing more than 84 million EU residents affected by mental health challenges. The Commission is focusing on the impact of digital technologies on youth mental health, referencing findings from a Eurobarometer survey and the Special Panel on Child Safety Online. These insights have informed the proposal for the EU Kids Act, which aims to enhance child safety online and provides new tools for parental oversight. This week, the Commission and UNICEF launched the Children's Prevention Toolkit, offering evidence-based guidance to improve child health, including mental health. Ongoing initiatives include €1.3 billion in funding for mental health promotion and equal treatment access, €9 million for professional development, and €11 million for capacity-building with WHO/Europe. The Commission reiterated commitments to prevention, recovery, and policy shaped by voices with lived experience.
Commission proposes accelerated standardisation to support EU competitiveness
The Commission presented a proposal to modernise the European standardisation system, targeting faster development of standards and increased representation of small- and medium-sized enterprises. The proposal revises Regulation (EU) No 1025/2012, introducing clearer deadlines and broader use of external technical specifications. Interim deliverables will support market access for innovative solutions, while provisions enhance inclusivity and transparency. The draft also codifies free access to standards referenced in EU law following Court of Justice rulings. An Expert Centre on European Standardisation is proposed to strengthen strategic alignment and international coordination, with final adoption pending Parliament and Council review.
Commission clarifies new Standardisation Regulation details
The Commission published a Q&A outlining the new Standardisation Regulation, describing standards' legal and market roles within the Single Market. Harmonised standards are set to be developed faster, with transition periods specified in final legislation. The public-private partnership model remains, but the Commission gains authority to send standardisation requests to designated organisations. The proposal mandates free access to standards referenced in EU law, impacting approximately 3,650 standards. International cooperation is highlighted, with reforms aimed at improving EU influence in global standard-setting and providing new revenue opportunities for European standardisation organisations.
Annual EU budget report details healthcare and research investments
The European Court of Auditors' Annual Report confirms the EU's accounts for 2025, noting €12.9 billion invested in research and innovation and continued support for healthcare, green transitions, and digital priorities. The Recovery and Resilience Facility enabled €87.3 billion in payments in 2025, supporting reforms and investments in healthcare, education, and business. Cohesion policy contributed €3.3 billion to affordable housing and €14.5 billion to climate adaptation. EU funding also supported medical research, with over 22,500 peer-reviewed publications and 130,000 researchers involved in upskilling. The Commission maintained controls to mitigate risk, achieving an estimated error rate of 3.8%.
NextGenerationEU implementation nears completion, impacting healthcare and research
The Commission's fifth annual report on the Recovery and Resilience Facility (RRF) states €450 billion in grants and loans disbursed, with Member States completing nearly 80% of milestones. Investments have supported modern health facilities, digitalisation, and training for health professionals. The RRF allocated €287 billion to green transition measures and €140 billion to digital transformation, supporting both healthcare infrastructure and research. Final payment requests and assessments are underway, with the facility expected to conclude by end-2026.
EU Legislation (Official Journal)
EU-Morocco scientific cooperation in healthcare and research extended under Horizon Europe
Agreement in the form of an Exchange of Letters (CELEX: 32026A2218, OJ L 2026/2218, 5 October 2026) amends conditions for Morocco’s participation in PRIMA. The revised agreement aligns with Decision (EU) 2024/1167, allowing Morocco to continue as a Participating State in Horizon Europe’s Partnership for Research and Innovation in the Mediterranean Area. The annex details mutual assistance arrangements for financial checks, audits, and cooperation with OLAF and EPPO. The agreement is provisionally applied pending entry into force.
Council Decision (EU) 2026/2217 approves provisional application of EU-Morocco research agreement
Council Decision (EU) 2026/2217 (CELEX: 32026D2217, OJ L 2026/2217, 5 October 2026) authorises the signing and provisional application of the amended EU-Morocco scientific cooperation agreement. The decision facilitates Morocco’s continued participation in PRIMA under Horizon Europe, pending full entry into force.
Council Decision (EU) 2026/2219 finalises EU-Morocco PRIMA agreement
Council Decision (EU) 2026/2219 (CELEX: 32026D2219, OJ L 2026/2219, 5 October 2026) concludes the amended agreement between the EU and Morocco for scientific and technological cooperation in PRIMA. The decision follows successful negotiations and provisional application, aligning Morocco’s participation with Horizon Europe rules.
Commission Implementing Regulation (EU) 2026/2201 alters biocidal product authorisation holder
Implementing Regulation (EU) 2026/2201 (CELEX: 32026R2201, OJ L 2026/2201, 5 October 2026) amends Implementing Regulation (EU) 2023/1763, transferring the Union authorisation for the biocidal product family 'Lactic acid Family – Quatchem' from Neogen Italia S.r.l. to Hypred SAS. The change follows an ECHA opinion and updates the annex to reflect the new authorisation holder.
Commission Implementing Regulation (EU) 2026/2203 updates biocidal product family authorisation
Implementing Regulation (EU) 2026/2203 (CELEX: 32026R2203, OJ L 2026/2203, 5 October 2026) amends Implementing Regulation (EU) 2024/2175 for the 'Contec Calcium Hypochlorite Product Family'. Changes include extended shelf life, new yeasticidal claims, and increased contact time in meta SPC 1. ECHA confirmed these as minor changes, and the annex was replaced accordingly.
Commission Implementing Regulation (EU) 2026/2199 cancels biocidal product authorisation for Nordkalk QL 0-2
Implementing Regulation (EU) 2026/2199 (CELEX: 32026R2199, OJ L 2026/2199, 5 October 2026) cancels the Union authorisation for Nordkalk QL 0-2 following a request from Nordkalk AB. Existing stocks may be placed on the market until 25 April 2027 and used until 25 October 2027.
EU Council
Upcoming Employment, Social Policy, Health and Consumer Affairs Council to address health and equality
Ministers will adopt a recommendation on housing exclusion and homelessness and discuss expectations for the forthcoming Quality Jobs Act. Conclusions on equality as a driver for competitiveness are also scheduled.
